DIAGEO PLC financials
Also U.S.-listed. DIAGEO PLC is also a foreign private issuer filing with the U.S. SEC. View its EDGAR financials: DEO — DIAGEO plc
DIAGEO PLC
Country: GB Reporting currency: USD Latest annual report: 2025-06-30
LEI:
213800ZVIELEA55JMJ32 Financial statements
(USD, as reported — unscaled; 106 line items across 3 annual periods)
| Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income statement | |||
| Revenue | $27.96B | $27.89B | $28.27B |
| Cost of sales | $8.07B | $8.07B | $8.29B |
| Gross profit | $12.17B | $12.20B | $12.27B |
| Operating profit (EBIT) | $4.33B | $6.00B | $5.55B |
| Finance costs | $1.25B | $1.28B | $1.12B |
| Profit before tax | $3.54B | $5.46B | $5.64B |
| Income tax expense | $999.0M | $1.29B | $1.16B |
| Profit for the year | $2.54B | $4.17B | $4.48B |
| — attributable to NCI | $184.0M | $296.0M | $34.0M |
| Total comprehensive income | $3.34B | $3.68B | $4.00B |
| Per share | |||
| Basic EPS | $1.06 | $1.73 | $1.96 |
| Diluted EPS | $1.06 | $1.73 | $1.96 |
| Cash flow statement | |||
| Cash generated from operations | $6.21B | $6.07B | $5.74B |
| Net cash from operating activities | $4.30B | $4.11B | $3.64B |
| Income taxes paid | $1.11B | $1.10B | $1.44B |
| Net cash from investing activities | -$1.72B | -$1.59B | -$1.43B |
| Net cash from financing activities | -$1.49B | -$3.11B | -$3.04B |
| Dividends paid | $2.44B | $2.36B | $2.19B |
| Net change in cash | $1.08B | -$596.0M | -$831.0M |
| Balance sheet | |||
| Total assets | $49.32B | $45.47B | — |
| Non-current assets | $31.82B | $30.35B | — |
| Intangible assets & goodwill | $14.78B | $14.81B | — |
| Current assets | $17.50B | $15.13B | — |
| Inventories | $10.66B | $9.72B | — |
| Trade & other receivables | $3.50B | $3.49B | — |
| Cash & equivalents | $2.20B | $1.13B | $1.81B |
| Total equity | $13.18B | $12.07B | $11.71B |
| — attributable to owners | $11.09B | $10.03B | — |
| Non-controlling interests | $2.09B | $2.04B | — |
| Non-current liabilities | $25.43B | $23.54B | — |
| Long-term borrowings | $20.82B | $18.62B | — |
| Current liabilities | $10.71B | $9.87B | — |
| Trade & other payables | $6.95B | $6.35B | — |
| Deferred tax liabilities | $2.94B | $2.95B | — |
| Derived metrics | |||
| Operating margin | 15.5% | 21.5% | 19.6% |
| Net margin | 9.1% | 14.9% | 15.8% |
| Return on equity | 19.3% | 34.5% | 38.3% |
| Cash conversion ratio | 1.69× | 0.99× | 0.81× |
| Other reported items | |||
| Adjusted Weighted Average Shares | 2228.0M | 2239.0M | 2271.0M |
| Adjustments For Decrease Increase In Inventories | -$470.0M | -$156.0M | -$810.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -$49.0M | -$66.0M | $142.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $1.72B | $493.0M | $1.30B |
| Adjustments For Finance Income Cost | -$771.0M | -$885.0M | -$712.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $22.0M | -$18.0M | -$31.0M |
| Bank Overdrafts Classified As Cash Equivalents | $22.0M | $21.0M | $45.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | $2.18B | $1.11B | $1.77B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $35.0M | $6.0M | $404.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | $183.0M | $277.0M | -$66.0M |
| Comprehensive Income Attributable To Owners of Parent | $3.16B | $3.40B | $4.06B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | $2.93B | $2.88B | — |
| Current Provisions | $223.0M | $97.0M | — |
| Current Tax Assets Current | $354.0M | $304.0M | — |
| Current Tax Liabilities Current | $138.0M | $136.0M | — |
| Decrease Increase Through Tax On Sharebased Payment Transactions | -$3.0M | — | -$7.0M |
| Deferred Tax Assets | $150.0M | $143.0M | — |
| Dilutive Effect of Share Options On Number of Ordinary Shares | 6.0M | 5.0M | 7.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | $2.30B | $2.24B | $2.06B |
| Dividends Paid To Noncontrolling Interests | $138.0M | $117.0M | $117.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | $1.40B | — | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | $0.63 | $0.63 | — |
| Dividends Received Classified As Operating Activities | $175.0M | $269.0M | $271.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$35.0M | -$33.0M | -$76.0M |
| Finance Income | $480.0M | $400.0M | $409.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | $15.0M | -$16.0M | $46.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -$7.0M | -$14.0M | -$193.0M |
| Increase Decrease In Working Capital | $77.0M | $768.0M | $1.41B |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | -$223.0M | -$178.0M |
| Increase Decrease Through Disposal of Subsidiary | $9.0M | — | — |
| Increase Decrease Through Treasury Share Transactions | $33.0M | $48.0M | $59.0M |
| Interest Paid Classified As Operating Activities | $980.0M | $1.02B | $822.0M |
| Interest Received Classified As Operating Activities | $181.0M | $156.0M | $157.0M |
| Investment Accounted For Using Equity Method | $5.33B | $5.03B | — |
| Issued Capital | $887.0M | $887.0M | — |
| Liabilities | $36.14B | $33.40B | — |
| Liabilities Included In Disposal Groups Classified As Held For Sale | $193.0M | $48.0M | — |
| Net Assets Liabilities | $13.18B | $12.07B | — |
| Noncurrent Biological Assets | $176.0M | $199.0M | — |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | $39.0M | $94.0M | — |
| Noncurrent Payables | $192.0M | $304.0M | — |
| Noncurrent Provisions | $316.0M | $300.0M | — |
| Noncurrent Recognised Assets Defined Benefit Plan | $1.16B | $1.15B | — |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $409.0M | $429.0M | — |
| Other Adjustments To Reconcile Profit Loss | $37.0M | $88.0M | $74.0M |
| Other Comprehensive Income | $803.0M | -$485.0M | -$482.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | $0 | -$1.0M | -$5.0M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | -$845.0M | -$70.0M | $499.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | $805.0M | -$423.0M | $85.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -$2.0M | -$62.0M | -$567.0M |
| Other Current Financial Assets | $524.0M | $355.0M | — |
| Other Current Financial Liabilities | $278.0M | $348.0M | — |
| Other Noncurrent Financial Assets | $623.0M | $373.0M | — |
| Other Noncurrent Financial Liabilities | $751.0M | $940.0M | — |
| Other Noncurrent Receivables | $38.0M | $38.0M | — |
| Other Operating Income Expense | -$4.18B | -$2.51B | -$3.06B |
| Other Reserves | $454.0M | -$91.0M | — |
| Proceeds From Current Borrowings | $83.0M | $387.0M | $521.0M |
| Proceeds From Issue of Bonds Notes and Debentures | $3.94B | $2.23B | $2.54B |
| Profit Loss Attributable To Ordinary Equity Holders of Parent Entity | $2.35B | $3.87B | $4.45B |
| Purchase of Interests In Investments Accounted For Using Equity Method | $84.0M | $133.0M | $112.0M |
| Reduction of Issued Capital | — | $997.0M | $1.54B |
| Repayments of Bonds Notes and Debentures | $2.42B | $1.67B | $1.65B |
| Repayments of Current Borrowings | $712.0M | $493.0M | $452.0M |
| Retained Earnings | $8.05B | $7.53B | — |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | $193.0M | $414.0M | $443.0M |
| Share Premium | $1.70B | $1.70B | — |
| Weighted Average Shares | 2222.0M | 2234.0M | 2264.0M |
Methodology
Every line item above is a fact tagged in DIAGEO PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.